|VRTX||VERTEX PHARMACEUTICALS INC||4.93%|
|MRK||MERCK & CO. NEW||4.79%|
|BMY||BRISTOL MYERS SQUIBB CO||4.78%|
|JNJ||JOHNSON & JOHNSON||4.71%|
|HCA||HCA HOLDINGS INC||4.64%|
|GILD||GILEAD SCIENCES INC||4.63%|
|LLY||ELI LILLY CORP||4.57%|
|TMO||THERMO FISHER SCIENTIFIC INC||4.44%|
|BAX||BAXTER INTERNATIONAL INC||3.73%|
|BDX||BECTON DICKINSON & CO||3.68%|
|CI||CIGNA CORP NEW||3.62%|
|CVS||CVS HEALTH CORPORATION||3.61%|
|UNH||UNITEDHEALTH GROUP INC||3.53%|
|ZBH||ZIMMER BIOMET HOLDINGS INC||1.54%|
|LH||LABORATORY CORP OF AMERICA||1.51%|
|EHC||ENCOMPASS HEALTH CORP NPV||1.35%|
|VEEV||VEEVA SYSTEMS INC CLASS A||1.24%|
|AMN||AMN HEALTHCARE SERVICES||1.24%|
|UTHR||UNITED THERAPEUTICS CORPS||1.11%|
|JAZZ||JAZZ PHARMACEUTICALS PLC||1.05%|
|HZNP||HORIZON THERAPEUTICS PLC||1.02%|
|CTLT||CATALENT INC USD 0.01||0.99%|
|OSH||OAK STREET HEALTH, INC.||0.94%|
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2022 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.